vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and KIRBY CORP (KEX). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $844.1M, roughly 2.0× KIRBY CORP). Edwards Lifesciences runs the higher net margin — 23.1% vs 9.6%, a 13.5% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 7.4%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs 1.2%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Kirby Corporation, headquartered in Houston, Texas, is the largest tank barge operator in the United States, transporting bulk liquid products throughout the Mississippi River System, on the Gulf Intracoastal Waterway, along all three U.S. Coasts, and in Alaska and Hawaii. Products transported by Kirby include petrochemicals, black oil, refined petroleum products, and agricultural chemical products by tank barge. Kirby also owns and operates eight ocean-going barge and tug units transporting ...

EW vs KEX — Head-to-Head

Bigger by revenue
EW
EW
2.0× larger
EW
$1.6B
$844.1M
KEX
Growing faster (revenue YoY)
EW
EW
+9.3% gap
EW
16.7%
7.4%
KEX
Higher net margin
EW
EW
13.5% more per $
EW
23.1%
9.6%
KEX
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
1.2%
KEX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EW
EW
KEX
KEX
Revenue
$1.6B
$844.1M
Net Profit
$380.7M
$81.3M
Gross Margin
78.0%
Operating Margin
1.8%
12.8%
Net Margin
23.1%
9.6%
Revenue YoY
16.7%
7.4%
Net Profit YoY
6.8%
6.6%
EPS (diluted)
$0.66
$1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
KEX
KEX
Q1 26
$1.6B
$844.1M
Q4 25
$1.6B
$851.8M
Q3 25
$1.6B
$871.2M
Q2 25
$1.5B
$855.5M
Q1 25
$1.4B
$785.7M
Q4 24
$1.4B
$802.3M
Q3 24
$1.4B
$831.1M
Q2 24
$1.4B
$824.4M
Net Profit
EW
EW
KEX
KEX
Q1 26
$380.7M
$81.3M
Q4 25
$91.2M
$91.8M
Q3 25
$291.1M
$92.5M
Q2 25
$333.2M
$94.3M
Q1 25
$358.0M
$76.0M
Q4 24
$385.6M
$42.8M
Q3 24
$3.1B
$90.0M
Q2 24
$366.3M
$83.9M
Gross Margin
EW
EW
KEX
KEX
Q1 26
78.0%
Q4 25
78.1%
Q3 25
77.8%
Q2 25
77.5%
Q1 25
78.7%
Q4 24
78.9%
Q3 24
80.6%
Q2 24
79.9%
Operating Margin
EW
EW
KEX
KEX
Q1 26
1.8%
12.8%
Q4 25
9.6%
15.2%
Q3 25
19.8%
14.8%
Q2 25
26.8%
15.4%
Q1 25
27.9%
13.4%
Q4 24
22.6%
6.3%
Q3 24
25.9%
15.3%
Q2 24
26.8%
14.6%
Net Margin
EW
EW
KEX
KEX
Q1 26
23.1%
9.6%
Q4 25
5.8%
10.8%
Q3 25
18.7%
10.6%
Q2 25
21.7%
11.0%
Q1 25
25.3%
9.7%
Q4 24
27.8%
5.3%
Q3 24
226.7%
10.8%
Q2 24
26.7%
10.2%
EPS (diluted)
EW
EW
KEX
KEX
Q1 26
$0.66
$1.50
Q4 25
$0.16
$1.68
Q3 25
$0.50
$1.65
Q2 25
$0.56
$1.67
Q1 25
$0.61
$1.33
Q4 24
$0.65
$0.74
Q3 24
$5.13
$1.55
Q2 24
$0.61
$1.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
KEX
KEX
Cash + ST InvestmentsLiquidity on hand
$58.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.4B
Total Assets
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
KEX
KEX
Q1 26
$58.0M
Q4 25
$4.2B
$78.8M
Q3 25
$3.8B
$47.0M
Q2 25
$4.1B
$68.4M
Q1 25
$3.9B
$51.1M
Q4 24
$4.0B
$74.4M
Q3 24
$4.4B
$67.1M
Q2 24
$2.0B
$53.5M
Total Debt
EW
EW
KEX
KEX
Q1 26
Q4 25
$919.3M
Q3 25
$1.0B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$874.9M
Q3 24
$978.6M
Q2 24
$1.0B
Stockholders' Equity
EW
EW
KEX
KEX
Q1 26
$3.4B
Q4 25
$10.3B
$3.4B
Q3 25
$10.2B
$3.4B
Q2 25
$10.5B
$3.4B
Q1 25
$10.1B
$3.3B
Q4 24
$10.0B
$3.4B
Q3 24
$9.5B
$3.3B
Q2 24
$7.4B
$3.3B
Total Assets
EW
EW
KEX
KEX
Q1 26
Q4 25
$13.7B
$6.0B
Q3 25
$13.3B
$6.1B
Q2 25
$13.5B
$6.1B
Q1 25
$13.0B
$6.0B
Q4 24
$13.1B
$5.9B
Q3 24
$13.0B
$5.9B
Q2 24
$10.1B
$5.9B
Debt / Equity
EW
EW
KEX
KEX
Q1 26
Q4 25
0.27×
Q3 25
0.31×
Q2 25
0.33×
Q1 25
0.33×
Q4 24
0.26×
Q3 24
0.30×
Q2 24
0.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
KEX
KEX
Operating Cash FlowLast quarter
$97.7M
Free Cash FlowOCF − Capex
$49.4M
FCF MarginFCF / Revenue
5.9%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
1.20×
TTM Free Cash FlowTrailing 4 quarters
$497.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
KEX
KEX
Q1 26
$97.7M
Q4 25
$450.9M
$312.2M
Q3 25
$573.7M
$227.5M
Q2 25
$290.2M
$93.9M
Q1 25
$280.4M
$36.5M
Q4 24
$-127.5M
$247.4M
Q3 24
$351.8M
$206.5M
Q2 24
$371.5M
$179.3M
Free Cash Flow
EW
EW
KEX
KEX
Q1 26
$49.4M
Q4 25
$353.5M
$265.2M
Q3 25
$516.2M
$160.3M
Q2 25
$240.9M
$22.4M
Q1 25
$224.4M
$-42.1M
Q4 24
$-177.3M
$150.7M
Q3 24
$299.9M
$130.1M
Q2 24
$286.1M
$90.8M
FCF Margin
EW
EW
KEX
KEX
Q1 26
5.9%
Q4 25
22.5%
31.1%
Q3 25
33.2%
18.4%
Q2 25
15.7%
2.6%
Q1 25
15.9%
-5.4%
Q4 24
-12.8%
18.8%
Q3 24
22.1%
15.7%
Q2 24
20.9%
11.0%
Capex Intensity
EW
EW
KEX
KEX
Q1 26
5.7%
Q4 25
6.2%
5.5%
Q3 25
3.7%
7.7%
Q2 25
3.2%
8.4%
Q1 25
4.0%
10.0%
Q4 24
3.6%
12.0%
Q3 24
3.8%
9.2%
Q2 24
6.2%
10.7%
Cash Conversion
EW
EW
KEX
KEX
Q1 26
1.20×
Q4 25
4.94×
3.40×
Q3 25
1.97×
2.46×
Q2 25
0.87×
1.00×
Q1 25
0.78×
0.48×
Q4 24
-0.33×
5.78×
Q3 24
0.11×
2.30×
Q2 24
1.01×
2.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

KEX
KEX

Marine transportation$497.2M59%
Distribution and services$346.9M41%

Related Comparisons